GH Research PLC (NASDAQ:GHRS) Shares Sold by Barclays PLC

Barclays PLC reduced its stake in shares of GH Research PLC (NASDAQ:GHRSFree Report) by 69.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,984 shares of the company’s stock after selling 13,925 shares during the period. Barclays PLC’s holdings in GH Research were worth $40,000 at the end of the most recent quarter.

Separately, RA Capital Management L.P. lifted its position in shares of GH Research by 1.3% in the 3rd quarter. RA Capital Management L.P. now owns 6,686,689 shares of the company’s stock worth $44,734,000 after buying an additional 85,000 shares during the last quarter. Institutional investors and hedge funds own 56.90% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Canaccord Genuity Group reduced their price target on shares of GH Research from $31.00 to $28.00 and set a “buy” rating on the stock in a research report on Monday, November 18th. HC Wainwright restated a “buy” rating and issued a $40.00 price target on shares of GH Research in a research report on Friday.

Get Our Latest Analysis on GHRS

GH Research Stock Performance

GH Research stock opened at $8.57 on Friday. The company has a market cap of $445.88 million, a P/E ratio of -10.85 and a beta of 0.84. The firm’s 50-day moving average is $8.44 and its 200-day moving average is $9.20. GH Research PLC has a 1 year low of $5.50 and a 1 year high of $14.99.

About GH Research

(Free Report)

GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).

Read More

Want to see what other hedge funds are holding GHRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GH Research PLC (NASDAQ:GHRSFree Report).

Institutional Ownership by Quarter for GH Research (NASDAQ:GHRS)

Receive News & Ratings for GH Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GH Research and related companies with MarketBeat.com's FREE daily email newsletter.